We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AMGN market cap is 141.58B. The company's latest EPS is USD 12.4960 and P/E is 21.08.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.9B | 8.2B | 7.45B | 8.39B | 8.5B |
| Operating Income | 2.04B | 1.52B | 1.59B | 342M | 3.97B |
| Net Income | 1.73B | 767M | -113M | 746M | 2.83B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.36B | 25.42B | 25.98B | 26.32B | 28.19B |
| Operating Income | 9.67B | 9.14B | 7.64B | 9.67B | 9.38B |
| Net Income | 7.84B | 7.26B | 5.89B | 6.55B | 6.72B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 90.53B | 97.15B | 92.98B | 90.91B | 90.88B |
| Total Liabilities | 82.88B | 90.92B | 87.96B | 84.98B | 83.36B |
| Total Equity | 7.66B | 6.23B | 5.02B | 5.93B | 7.53B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.71B | 62.95B | 61.17B | 65.12B | 97.15B |
| Total Liabilities | 50.03B | 53.54B | 54.47B | 61.46B | 90.92B |
| Total Equity | 9.67B | 9.41B | 6.7B | 3.66B | 6.23B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.93B | 8.47B | 689M | 3.15B | 6.72B |
| Investing | 885M | -26.2B | -217M | -434M | -644M |
| Financing | 18.29B | 21.05B | -1.71B | -4.36B | -8.01B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.15B | 10.5B | 9.26B | 9.72B | 8.47B |
| Investing | 5.71B | -5.4B | 733M | -6.04B | -26.2B |
| Financing | -15.77B | -4.87B | -8.27B | -4.04B | 21.05B |
| Market Cap | 141.58B |
| Price to Earnings Ratio | 21.08 |
| Price to Sales Ratio | 5.02 |
| Price to Cash Ratio | 12.94 |
| Price to Book Ratio | 22.72 |
| Dividend Yield | 3.61% |
| Shares Outstanding | 537.53M |
| Average Volume (1 week) | 3.99M |
| Average Volume (1 Month) | 4.65M |
| 52 Week Change | -5.20% |
| 52 Week High | 346.85 |
| 52 Week Low | 253.30 |
| Spread (Intraday) | 2.41 (0.91%) |
| Company Name | Amgen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amgen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
